Department of Health and Human Services logo

Medical Product Safety

Goal

Introduction

Modifications to Objectives and Subobjectives

Progress Toward Healthy People 2010 Targets

Progress Toward Elimination of Health Disparities

Opportunities and Challenges

Emerging Issues

Progress Quotient Chart

Disparities Table (See below)

Race and Ethnicity

Gender, Education, and Disability

Objectives and Subobjectives

References

Related Objectives From Other Focus Areas

> Back to the Table of Contents

Midcourse Review  >  Table of Contents  >  Focus Area 17: Medical Product Safety  >  Objectives and Subobjectives
Midcourse Review Healthy People 2010 logo
Medical Product Safety Focus Area 17

Objectives and Subobjectives



Goal: Ensure the safe and effective use of medical products.

As a result of the Healthy People 2010 Midcourse Review, changes were made to the Healthy People 2010 objectives and subobjectives. These changes are specific to the following situations:

  • Changes in the wording of an objective to more accurately describe what is being measured.
  • Changes to reflect a different data source or new science.
  • Changes resulting from the establishment of a baseline and a target (that is, when a formerly developmental objective or subobjective became measurable).
  • Deletion of an objective or subobjective that lacked a data source.
  • Correction of errors and omissions in Healthy People 2010.

Revised baselines and targets for measurable objectives and subobjectives do not fall into any of the above categories and, thus, are not considered a midcourse review change.1

When changes were made to an objective, three sections are displayed:

  1. In the Original Objective section, the objective as published in Healthy People 2010 in 2000 is shown.
  2. In the Objective With Revisions section, strikethrough indicates text deleted, and underlining is used to show new text.
  3. In the Revised Objective section, the objective appears as revised as a result of the midcourse review.

Details of the objectives and subobjectives in this focus area, including any changes made at the midcourse, appear on the following pages.

1See Technical Appendix for more information on baseline and target revisions.



ORIGINAL OBJECTIVE
17-1. (Developmental) Increase the proportion of health care organizations that are linked in an integrated system that monitors and reports adverse events.

17-1a. Health care organizations that are linked in an integrated system that monitors and reports adverse events associated with medical therapies.

17-1b. Health care organizations that are linked in an integrated system that monitors and reports adverse events associated with medical devices.

Potential data sources: Office of Postmarketing Drug Risk Assessment (OPDRA), MEDWATCH, and Manufacturer and User Device Experience (MAUDE) Database, FDA.

OBJECTIVE WITH REVISIONS
(Including subobjective deleted)
17-1. (Developmental) Increase the proportion of health care organizations that are linked in an integrated system that monitors and reports adverse events are monitoring and analyzing adverse events associated with medical therapies within their systems.

17-1a.* Health care organizations that are linked in an integrated system that monitors and reports monitoring and analyzing adverse events associated with medical therapies within their systems.

17-1b. (Subobjective deleted due to lack of data source) Health care organizations that are linked in an integrated system that monitors and reports adverse events associated with medical devices.

Target: 90 percent.

Baseline: 82 percent of health care organizations were monitoring and analyzing adverse events associated with medical therapies within their systems in 1998.

Target setting method: 10 percent improvement.

Potential dData sources: National Survey of Pharmacy Practice in Acute Care Settings, Office of Postmarketing Drug Risk Assessment (OPDRA), MedWatch, and Manufacturer and User Device Experience (MAUDE) Database, FDAAmerican Society of Health System Pharmacists (ASHP).

* For data control purposes, subobjectives are not renumbered.

REVISED OBJECTIVE
17-1. Increase the proportion of health care organizations that are monitoring and analyzing adverse events associated with medical therapies within their systems.

17-1a.* Health care organizations that are monitoring and analyzing adverse events associated with medical therapies within their systems.

Target: 90 percent.

Baseline: 82 percent of health care organizations were monitoring and analyzing adverse events associated with medical therapies within their systems in 1998.

Target setting method: 10 percent improvement.

Data source: National Survey of Pharmacy Practice in Acute Care Settings, American Society of Health System Pharmacists (ASHP).

* For data control purposes, subobjectives are not renumbered.



ORIGINAL OBJECTIVE
17-2. (Developmental) Increase the use of linked, automated systems to share information.

17-2a. By health care professionals in hospitals and comprehensive, integrated health care systems.

17-2b. By pharmacists and other dispensers.

Potential data sources: National Survey of Pharmacy Practice in Acute Care Settings and Survey of Managed Care and Ambulatory Care Pharmacy Practice in Integrated Health Systems, American Society of Hospital Pharmacists (ASHP).

OBJECTIVE WITH REVISIONS
17-2. (Developmental) Increase the proportion of health care providers and organizations that are usinguse of linked, automated systems to share information technology.

17-2a. By health care professionals in hospitals and comprehensive, integrated health care systems.

17-2b. By pharmacists and other dispensers.

Target and baseline:
Objective Increase in Health Care Providers and Organizations Using Information Technology
2000 Baseline (unless noted)

Percent
2010 Target

Percent
17-2a. Health care providers in health care organizations using electronic medical records 12 18
17-2b. Pharmacists in managed care and integrated health systems using electronic medical records 31 (1999) 46
17-2c. General and children’s hospitals using computerized prescriber order entry 4.3 (2001) 6.0
17-2d. Urban acute care facilities using computerized prescriber order entry 5.0 (2003) 7.0

Target setting method: 50 percent improvement.

Potential dData sources: Healthcare Information and Management Systems Society (HIMSS); American Society of Health System Pharmacists (ASHP); The Leapfrog Group.National Survey of Pharmacy Practice in Acute Care Settings and Survey of Managed Care and Ambulatory Care Pharmacy Practice in Integrated Health Systems, American Society of Hospital Pharmacists (ASHP).

REVISED OBJECTIVE
17-2. Increase the proportion of health care providers and organizations that are using information technology.

Target and baseline:
Objective Increase in Health Care Providers and Organizations Using Information Technology
2000 Baseline (unless noted)

Percent
2010 Target

Percent
17-2a. Health care providers in health care organizations using electronic medical records 12 18
17-2b. Pharmacists in managed care and integrated health systems using electronic medical records 31 (1999) 46
17-2c. General and children’s hospitals using computerized prescriber order entry 4.3 (2001) 6.0
17-2d. Urban acute care facilities using computerized prescriber order entry 5.0 (2003) 7.0

Target setting method: 50 percent improvement.

Data sources: Healthcare Information and Management Systems Society (HIMSS); American Society of Health System Pharmacists (ASHP); The Leapfrog Group.



OBJECTIVE DELETED
17-3. (Objective deleted due to lack of data source) (Developmental) Increase the proportion of primary care providers, pharmacists, and other health care professionals who routinely review with their patients aged 65 years and older and patients with chronic illnesses or disabilities all new prescribed and over-the-counter medicines.



NO CHANGE IN OBJECTIVE
17-4. (Developmental) Increase the proportion of patients receiving information that meets guidelines for usefulness when their new prescriptions are dispensed.

Potential data source: Patient/Consumer Medication Information Survey, FDA.



NO CHANGE IN OBJECTIVE
17-5. Increase the proportion of patients who receive verbal counseling from prescribers and pharmacists on the appropriate use and potential risks of medications.

Target and baseline:
Objective Increase in Patients Receiving Oral Counseling From
1998 Baseline

Percent
2010 Target

Percent
17-5a. Prescribers 24 95
17-5b. Pharmacists 14 95

Target setting method: 296 percent improvement for prescribers and 579 percent improvement for pharmacists. (Better than the best will be used when data are available.)

Data source: National Survey of Prescription Drug Information Received by Consumers, FDA.



NO CHANGE IN OBJECTIVE
(Data updated and footnoted)

17-6. Increase the proportion of persons who donate blood, and in so doing ensure an adequate supply of safe blood.

Target: 8 percent.

Baseline: 61 percent of the total population aged 18 years and older donated blood in 1998.1

Target setting method: Better than the best.2

Data source: National Health Interview Survey (NHIS), CDC, NCHS.*

* The data source changed from the American Association of Blood Banks.
1 Baseline and baseline year revised from 5 and 1994 after November 2000 publication.
2 Target setting method revised from 60 percent improvement after November 2000 publication with the availability of population-level data.



<<  Previous—Disparities Table: Income, Location, and Disability   |   Table of Contents  |   Next—References   >>


[ Top ]